Profil bibliographique

Alessandro Bressan

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

53Publications signalées

432Citations signalées

0Affiliations récentes

Domaines associés

HER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies ResearchRadiopharmaceutical Chemistry and ApplicationsCoagulation, Bradykinin, Polyphosphates, and AngioedemaAdvanced Breast Cancer Therapies

Publications récentes

2025 conference-abstractOpenAlex

Abstract P1-01-25: Elacestrant vs SOC in ER+, HER2- advanced or metastatic breast cancer (mBC) with ESR1-mutated tumors: ESR1 allelic frequencies and clinical activity from the phase 3 EMERALD trial

Aditya Bardia, Javier Cortés, Francois Clement-Bidard, Guillermo Streich et autres

2 citationsClinical Cancer Research

Accès ouvert 2024 articleOpenAlex

The Dual PIM / FLT3 Inhibitor MEN1703 Combines Synergistically With Gilteritinib in FLT3 ‐ ITD ‐Mutant Acute Myeloid Leukaemia

Sonia Zicari, Giuseppe Merlino, Alessandro Paolì, Alessio Fiascarelli et autres

4 citationsJournal of Cellular and Molecular Medicine

2024 conference-abstractOpenAlex

Abstract 665: MEN1703/SEL24 exhibits promising antitumoral activity in preclinical models of myelofibrosis both as single agent and combined with ruxolitinib

Maria Luisa Iannitto, Diego Bisignano, Sonia Zicari, Francesco Belli et autres

0 citationsCancer Research

2023 conference-abstractOpenAlex

Tagraxofusp Shows Promising Anti-Tumoral Efficacy in Preclinical in Vitro Models of Myelofibrosis, Both As a Single Agent and in Combination with Janus Kinase Inhibitors

Maria Luisa Iannitto, Diego Bisignano, Alessio Fiascarelli, Simone Talucci et autres

2 citationsBlood

Accès ouvert 2023 articleOpenAlex

Six Sigma can significantly reduce costs of poor quality of the surgical instruments sterilization process and improve surgeon and operating room personnel satisfaction

Andrea Saporito, Claudio Tassone, Antonio Di Iorio, Marcella Barbieri Saraceno et autres

12 citationsScientific Reports

2023 articleOpenAlex

NETosis in Acute Thrombotic Disorders

Alessandro Bressan, Elisabetta Faggin, Maristella Donato, Luca Tonon et autres

10 citationsSeminars in Thrombosis and Hemostasis

2023 conference-abstractOpenAlex

Abstract 2849: The oral SERD Elacestrant in combination with the PI3K inhibitor MEN1611 inhibits tumor growth in ER+/HER2- breast cancer in vitro and in PDX models

Giuseppe Merlino, Alessio Fiascarelli, Simone Talucci, Patrizia Tunici et autres

2 citationsCancer Research

Accès ouvert 2023 otherOpenAlex

Data from MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors

Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, Alessandro Bressan et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Data from MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors

Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, Alessandro Bressan et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Figure S1 from MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors

Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, Alessandro Bressan et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Figure S2 from MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors

Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, Alessandro Bressan et autres

0 citations

Accès ouvert 2023 supplementary-materialsOpenAlex

Supplementary Table S3 from MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors

Giuseppe Merlino, Alessio Fiascarelli, Mario Bigioni, Alessandro Bressan et autres

0 citations

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.